Market Snapshot

BSE Sensex: 76676.75 0.23%
BSE 500: 33823.75 0.14%
BSE 200: 10570.49 0.15%
BSE 100: 24359.49 0.20%
BSE MidCap: 43192.88 -0.24%
BSE SmallCap: 51460.18 0.12%
BSE BANKEX: 55378.5 0.17%
BSE IT: 42800.65 0.03%
Nifty 50: 23200.85 0.11%
Nifty 500: 21504.15 0.11%
Nifty 200: 12951.15 0.12%
Nifty 100: 23807.45 0.16%
Nifty Midcap 100: 53657.6 -0.04%
Nifty Small 100: 17247.25 -0.06%
Nifty IT: 43077.55 0.04%
Nifty PSU Bank: 6168.05 0.38%

News:

Hathway Cable slides after Q3 ...
Adani Green Energy Ltd Spikes ...
Ask Automotive arm commences p...
Sayaji Hotels (Pune) hits the ...
HDFC AMC rises after Q3 PAT cl...

Sandu Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

15 Jan 2025 | 09:44 AM

54.00

0.52 (0.97%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-23.08%

Return (1Y)

Underperformed BSE Sensex by 27.4%
More Volatile

2.24%

Standard Deviation (1Y)

Higher than BSE Sensex by 1.36%
Not so consistent

4/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter
61 days ago

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter

15 - Nov - 2024 12:00 AM | 61 days ago

Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023.
Particulars Quarter Ended
Sep. 2024 Sep. 2023 % Var.
Sales 17.70 16.61 7
OPM % 5.14 4.94 -
PBDT 0.91 0.90 1
PBT 0.74 0.76 -3
NP 0.50 0.55 -9
Powered by Capital Market - Live News
Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter
61 days ago

Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter

15 - Nov - 2024 12:00 AM | 61 days ago

Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023.
Particulars Quarter Ended
Sep. 2024 Sep. 2023 % Var.
Sales 17.70 16.61 7
OPM % 5.14 4.88 -
PBDT 0.91 0.89 2
PBT 0.74 0.76 -3
NP 0.50 0.55 -9
Powered by Capital Market - Live News
Sandu Pharmaceuticals declare Quarterly Result
71 days ago

Sandu Pharmaceuticals declare Quarterly Result

05 - Nov - 2024 12:00 AM | 71 days ago

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024
Powered by Capital Market - Live News
Board of Sandu Pharmaceuticals recommends final dividend
155 days ago

Board of Sandu Pharmaceuticals recommends final dividend

13 - Aug - 2024 12:00 AM | 155 days ago

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 August 2024, inter alia, have recommended the final dividend of Rs 0.8 per equity Share (i.e. 8%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Sandu Pharmaceuticals Ltd is trading very close to its 52 Week Low

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	17.70	16.61	7
OPM %	5.14	4.94	-
PBDT	0.91	0.90	1
PBT	0.74	0.76	-3
NP	0.50	0.55	-9

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	17.70	16.61	7
OPM %	5.14	4.88	-
PBDT	0.91	0.89	2
PBT	0.74	0.76	-3
NP	0.50	0.55	-9

General Notifications

My Notifications

Research Notifications

Sandu Pharmaceuticals Ltd Share Price – BSE Pharmaceuticals, Small Cap

54.00 0.52 (0.97%)

News & Announcements

Price vs Volume

Stock Trivia

Sandu Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

54.00

0.52 (0.97%)